# Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell

> **NCT05269654** · NA · UNKNOWN · sponsor: **Goldman, Butterwick, Fitzpatrick and Groff** · enrollment: 20 (estimated)

## Conditions studied

- Skin Laxity

## Interventions

- **DEVICE:** injectable poly-L-lactic acid
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT05269654
- **Lead sponsor:** Goldman, Butterwick, Fitzpatrick and Groff
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-04
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269654, "Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05269654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*